Hostname: page-component-7b7567c8c-jswmv Total loading time: 0 Render date: 2026-11-15T15:38:26.079Z Has data issue: false hasContentIssue false

Comorbidity in obsessive-compulsive disorder: focus on depression

Published online by Cambridge University Press:  16 April 2020

A Milanfranchi
Affiliation:
Institute of Psychiatry, University of Pisa, via Roma, 67, I-56100Pisa, Italy
D Marazziti*
Affiliation:
Institute of Psychiatry, University of Pisa, via Roma, 67, I-56100Pisa, Italy
C Pfanner
Affiliation:
Institute of Psychiatry, University of Pisa, via Roma, 67, I-56100Pisa, Italy
S Presta
Affiliation:
Institute of Psychiatry, University of Pisa, via Roma, 67, I-56100Pisa, Italy
P Lensi
Affiliation:
Institute of Psychiatry, University of Pisa, via Roma, 67, I-56100Pisa, Italy
S Ravagli
Affiliation:
Institute of Psychiatry, University of Pisa, via Roma, 67, I-56100Pisa, Italy
GB Cassano
Affiliation:
Institute of Psychiatry, University of Pisa, via Roma, 67, I-56100Pisa, Italy
*
*Correspondence and reprints.
Get access

Summary

The authors investigated the comorbidity between obsessive-compulsive disorder (OCD) and other psychiatric disorders in a group of 154 outpatients. The influence of an associate major depressive disorder (MDD) on the outcome of treatment with clomipramine was examined in a subgroup of 52 patients. The results showed that MDD was the most frequent disorder associated with OCD (almost 20% of the patients), followed by generalized anxiety and panic disorder. The co-presence of depression delayed the effect of clomipramine.

Information

Type
Original article
Copyright
Copyright © Elsevier, Paris 1995

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Article purchase

Temporarily unavailable

Submit a response

Comments

No Comments have been published for this article.